Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers

Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers

Abstract Background Breast cancers with 1–10% cell staining for estrogen receptor (ER) present particular clinical features. The clinical data of estrogen receptor expression level and treatment effect are limited, particularly regarding chemotherapy benefit. We evaluated the pathologic response to...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Hai-long Chen, Feng-bo Huang, Qiang Chen, Yong-chuan Deng
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: BMC 2023-09-01
Seri Bilgileri:BMC Cancer
Konular:
Breast cancer
Estrogen receptor
Neoadjuvant chemotherapy
Pathologic complete response
Prognosis
Online Erişim:https://doi.org/10.1186/s12885-023-11368-2

Internet

https://doi.org/10.1186/s12885-023-11368-2

Benzer Materyaller